On Jan 25, 2022 Metagenomi closed a Series B round and raised $175,000,000 from Bristol Myers Squibb, Deep Track Capital, Eventide Asset Management, Farallon Capital Management, Frazier Healthcare Partners, Humboldt Fund, Irving Investors, Leaps by Bayer, Marshall Wace, Millennium Management, Moderna Therapeutics, Novo Holdings, PFM Health Sciences, Pura Vida Investments, RA Capital Management, Surveyor Capital, featuring lead investors Farallon Capital Management, PFM Health Sciences.

About the company: Metagenomi is located at United States, North America.
“”

Company website: http://www.metagenomi.co